Published in Clin Physiol on June 01, 1988
Metabolic approaches to the treatment of ischemic heart disease: the clinicians' perspective. Heart Fail Rev (2002) 0.87
Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. J Virol (1994) 4.67
Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks. J Cell Biol (1993) 4.34
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Characterization of the budding compartment of mouse hepatitis virus: evidence that transport from the RER to the Golgi complex requires only one vesicular transport step. J Cell Biol (1994) 2.92
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med (2006) 2.55
Identification of proteins of Francisella tularensis induced during growth in macrophages and cloning of the gene encoding a prominently induced 23-kilodalton protein. Infect Immun (1997) 2.40
Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet (2003) 2.37
Risk factors for ischaemic heart-disease in normal men aged 40. Edinburgh-Stockholm Study. Lancet (1978) 2.32
Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet (1987) 2.23
Assembly of vaccinia virus: effects of rifampin on the intracellular distribution of viral protein p65. J Virol (1994) 2.17
Eps15 is a component of clathrin-coated pits and vesicles and is located at the rim of coated pits. J Biol Chem (1996) 2.16
Localization of the Lys, Asp, Glu, Leu tetrapeptide receptor to the Golgi complex and the intermediate compartment in mammalian cells. J Cell Biol (1994) 2.04
A case of chronic progressive rhinocerebral mucormycosis treated with liposomal amphotericin B and surgery. Clin Infect Dis (1993) 1.94
Identification and localization of polycystin, the PKD1 gene product. J Clin Invest (1996) 1.84
Characterization of a novel 63 kDa membrane protein. Implications for the organization of the ER-to-Golgi pathway. J Cell Sci (1993) 1.66
Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med (2009) 1.51
Assembly of vaccinia virus: incorporation of p14 and p32 into the membrane of the intracellular mature virus. J Virol (1995) 1.47
Cytokine expression in the liver during the early phase of murine tularemia. Infect Immun (1995) 1.39
Oligomerization of a trans-Golgi/trans-Golgi network retained protein occurs in the Golgi complex and may be part of its retention. J Biol Chem (1995) 1.30
Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med (2008) 1.30
Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials. Int J Obes Relat Metab Disord (2002) 1.29
Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction. Circulation (1986) 1.20
Automatic analysis of the EMG interference pattern. Electroencephalogr Clin Neurophysiol (1983) 1.19
Two-dimensional tortuosity of the superficial femoral artery in early atherosclerosis. J Vasc Res (1993) 1.19
Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care. J Intern Med (1998) 1.18
Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study. Ann Rheum Dis (2010) 1.17
Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med (2008) 1.11
Monoclonal antibody HFD9 identifies a novel 28 kDa integral membrane protein on the cis-Golgi. J Cell Sci (1995) 1.10
Effect of chlorophenoxyisobutyric acid (CPIB) on fat-mobilizing lipolysis and cyclic AMP levels in rat epididymal fat. Atherosclerosis (1973) 1.10
Geometric phases for mixed states in interferometry. Phys Rev Lett (2000) 1.09
Quantitative and qualitative serum lipoprotein analysis. Part 1. Studies in healthy men and women. Atherosclerosis (1975) 1.06
Orchestration of the protective immune response to intracellular bacteria: Francisella tularensis as a model organism. FEMS Immunol Med Microbiol (1996) 1.03
Surgical treatment of metastatic disease in the thyroid gland. J Surg Oncol (1981) 0.99
Arrhythmias and symptoms during treadmill testing three weeks after myocardial infarction in 100 patients. Br Heart J (1973) 0.98
Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensis. Vaccine (1995) 0.97
Identification of framework residues in a secreted recombinant antibody fragment that control production level and localization in Escherichia coli. J Biol Chem (1997) 0.95
Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease. J Intern Med (2006) 0.95
Serum triglycerides and fatty acid incorporation into human adipose tissue (TIAT). Their relations with adipose tissue characteristics and glucose tolerance. Acta Med Scand (1976) 0.92
Lipoprotein lipase in plasma after an oral fat load: relation to free fatty acids. J Lipid Res (1992) 0.92
Apolipoprotein B and A-I in relation to serum cholesterol and triglycerides in 43,000 Swedish males and females. Int J Clin Lab Res (1992) 0.91
Fatty acids incorporation into human adipose tissue in hypertriglyceridaemia. Eur J Clin Invest (1976) 0.91
Secondary hyperparathyroidism combined with uremia and giant cell containing tumor of the cervical spine. A case report. Scand J Urol Nephrol (1978) 0.89
Renal function assessed by two different formulas and incidence of myocardial infarction and death in middle-aged men and women. J Intern Med (2010) 0.89
Quantitative and qualitative serum lipoprotein analysis. Part 2. Studies in male survivors of myocardial infarction. Atherosclerosis (1975) 0.87
Lowering of HDL2b by probucol partly explains the failure of the drug to affect femoral atherosclerosis in subjects with hypercholesterolemia. A Probucol Quantitative Regression Swedish Trial (PQRST) Report. Arterioscler Thromb Vasc Biol (1995) 0.87
Gelfoam powder embolization of the hepatic artery in liver metastases of carcinoid tumors. Radiologe (1982) 0.87
A comparison between nicotinic acid and acipimox in hypertriglyceridaemia--effects on serum lipids, lipoproteins, glucose tolerance and tolerability. J Intern Med (1991) 0.87
Oral shedding of herpes simplex virus type 2. Sex Transm Infect (2004) 0.86
Effect of probucol treatment on the susceptibility of low density lipoprotein isolated from hypercholesterolemic patients to become oxidatively modified in vitro. Atherosclerosis (1990) 0.86
A role for the hinge/ear domain of the beta chains in the incorporation of AP complexes into clathrin-coated pits and coated vesicles. Cell Mol Life Sci (1997) 0.86
Personality and the prediction of weight loss and relapse in the treatment of obesity. Int J Eat Disord (1999) 0.85
D4 dopamine receptor gene exon III polymorphism and obesity risk. Eat Weight Disord (1998) 0.85
A case of massive hypertriglyceridaemia and impaired fatty acid incorporation into adipose tissue glycerides (FIAT), both corrected by nicotinic acid. Acta Med Scand (1973) 0.85
The quadriceps femoris muscle in 20-70-year-old subjects: relationship between knee extension torque, electrophysiological parameters, and muscle fiber characteristics. Muscle Nerve (1989) 0.85
Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction. Atherosclerosis (1986) 0.85
Probucol treatment decreases serum concentrations of diet-derived antioxidants. Arterioscler Thromb Vasc Biol (1995) 0.84
Targeting of frog prodermorphin to the regulated secretory pathway by fusion to proenkephalin. J Cell Biol (1991) 0.84
Fatty acid composition in serum lipids and adipose tissue in severe obesity before and after six weeks of weight loss. Int J Obes (1989) 0.84
Three-dimensional reconstruction of transmitter-identified central neurons by "en bloc" immunofluorescence histochemistry and confocal scanning microscopy. Exp Brain Res (1988) 0.84
Effect of verapamil on serum lipoproteins in patients with angina pectoris. Acta Med Scand Suppl (1984) 0.83
Failure of somatostatin to eliminate the glucagon release induced by baroreceptor unloading in the cat. Acta Physiol Scand (1978) 0.83
Somatostatin inhibits thyroid hormone secretion induced by exogenous TSH in man. J Clin Endocrinol Metab (1978) 0.83
Hypertriglyceridemia--acute pancreatitis--ischemic heart disease. A case study in a pair of monozygotic twins. Acta Med Scand (1987) 0.82
IL-1 beta and IL-6 in mouse parotid acinar cells: characterization of synthesis, storage, and release. Am J Physiol (1998) 0.82
Human evidence for the involvement of insulin-induced gene 1 in the regulation of plasma glucose concentration. Diabetologia (2006) 0.82
Antioxidants and atherosclerosis progression: unresolved questions. Curr Opin Lipidol (1994) 0.82
Effect of gemfibrozil on lipoprotein concentrations in different types of hyperlipoproteinaemia. Proc R Soc Med (1976) 0.82
Circulation, respiration and serotonin levels in carcinoid patients during neurolept anaesthesia. Anaesthesia (1983) 0.81
Detector electrode introduced by mediastinoscopy for atrial triggered cardiac pacing. A follow-up of electrode function in 82 patients. Br Heart J (1977) 0.81
Removal of exogenous plasma triglycerides in forearm muscle and subcutaneous tissue of hyper-and normotriglyceridaemic men. Eur J Clin Invest (1976) 0.81
Autonomic neuropathy--a complication less pronounced in patients with Type 1 diabetes mellitus who have lower blood glucose levels. Diabet Med (2000) 0.81
Effects of nicotinic acid and its derivatives on lipid metabolism and other metabolic factors related to atherosclerosis. Adv Exp Med Biol (1985) 0.81
Fatty acid turnover in the ischaemic compared to the non-ischaemic human heart. Mol Cell Biochem (1989) 0.80
Plasminogen activator inhibitor type-1 interacts exclusively with the proteinase domain of tissue plasminogen activator. Biochim Biophys Acta (1994) 0.80
Activation of coagulation factor VII during alimentary lipemia. Arterioscler Thromb (1994) 0.80
Long-term outcome of facial palsy in neuroborreliosis. Otol Neurotol (2005) 0.79
Effects of the peroxisome proliferator-activated receptor (PPAR)-δ agonist GW501516 on bone and muscle in ovariectomized rats. Endocrinology (2014) 0.79
Basal and pentagastrin-stimulated levels of calcitonin in thyroid and peripheral veins during normocalcemia and chronic hypercalcemia in humans. Ann Surg (1981) 0.79
Acute acalculous cholecystitis following trauma. Br J Surg (1982) 0.79
Beneficial effects of reduced intake of polyunsaturated fatty acids in the diet for one year in patients with systemic lupus erythematosus. Ann Rheum Dis (1990) 0.79
Fatty acid composition of serum and adipose tissue lipids in males with chronic renal failure. Relations to serum lipoproteins and clinical factors. Acta Med Scand (1982) 0.79
Phase II study of high dose toremifene in advanced breast cancer progressing during tamoxifene treatment. Anticancer Res (1991) 0.79
Weekly dose adriamycin as first line chemotherapy in advanced breast cancer. Anticancer Res (1991) 0.78
[2 limits of serum cholesterol levels are appropriate in the diagnosis and treatment of hypercholesterolemia]. Lakartidningen (1988) 0.78
The effects of diet and zinc treatment on the fatty acid composition of serum lipids and adipose tissue and on serum lipoproteins in two adolescent patients with acrodermatitis enteropathica. Am J Clin Nutr (1983) 0.78
Prostaglandin E1 (PGE1) in peripheral arteriographies. Acta Radiol Diagn (Stockh) (1973) 0.78
Effects of nicotinic acid on serum cholesterol concentrations of high density lipoprotein subfractions HDL2 and HDL3 in hyperlipoproteinaemia. J Intern Med (1990) 0.78
Neuropeptide Y is released together with noradrenaline from the human heart during exercise and hypoxia. Clin Physiol (1990) 0.78
Correlations between intravenous fat tolerance and serum lipoproteins in normal and atherosclerotic subjects. Atherosclerosis (1979) 0.77
Effects of nicotinic acid treatment on fatty acid composition of plasma lipids and adipose tissue in hyperlipidaemia. Scand J Clin Lab Invest (1992) 0.77
Effects of nicotinic acid on glucose tolerance and glucose incorporation into adipose tissue in hypertriglyceridaemia. Scand J Clin Lab Invest (1992) 0.77
On the relation between peripheral atherosclerosis and serum lipoproteins. Ups J Med Sci (1979) 0.77
Reptilian alcohol dehydrogenase. Heterogeneity relevant to class multiplicity of the mammalian enzyme. FEBS Lett (1992) 0.77
Predilection of atherosclerosis for the inner curvature in the femoral artery. A digitized angiography study. Arterioscler Thromb Vasc Biol (1995) 0.77
H.D.L. secretion from human intestinal tract. Lancet (1978) 0.77
Analogues of parathyroid hormone modified at positions 3 and 6. Effects on receptor binding and activation of adenylyl cyclase in kidney and bone. J Biol Chem (1991) 0.77
24-hour ECG frequency-domain measures in preeclamptic and healthy pregnant women during and after pregnancy. Hypertens Pregnancy (1999) 0.77